Nomic Bio Secures $42 Million in Oversubscribed Series B Funding to Enhance Protein Profiling Capabilities
Nomic Bio, a leader in protein profiling, has successfully completed a $42 million Series B funding round that was oversubscribed. This significant capital infusion will propel the company’s efforts to enhance its cutting-edge protein profiling platform and expand its commercial operations, catering to the rising demand in the proteomics field. Led by a prominent U.S.-based…